$14.00
▲ +$1.35
(+10.67%)
Vol 304K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$75.4M
ROE
-68.9%
Margin
-1199.5%
D/E
0.00
Beta
3.02
52W
$5–$56
Wall Street Consensus
16 analysts · Apr 20264
Strong Buy
8
Buy
4
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Similar Stocks
NERV
Minerva Neurosciences Inc
$28.1M
ARCT
Arcturus Therapeutics Holdings Inc
$174.2M
FENC
Fennec Pharmaceuticals Inc
$262.9M
NVCT
Nuvectis Pharma Inc
$193.4M
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9.5
$178.0M
ELTX
Elicio Therapeutics Inc
$139.2M
ZNTL
Zentalis Pharmaceuticals Inc
$97.5M
MGNX
MacroGenics Inc
$101.8M
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-2.11 | $-1.65 | +$0.46 |
| Sep 2025 | $-2.65 | $-1.92 | +$0.73 |
| Jun 2025 | $-2.62 | $-2.74 | $-0.12 |
| Mar 2025 | $-2.66 | $-2.49 | +$0.17 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -61.5% | -61.5% | -61.5% | -61.5% | -61.5% | -68.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1765.1% | -1120.1% | -1120.1% | -1120.1% | -1120.1% | -1199.5% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 | 6.71 |
Key Ratios
ROA (TTM)
-45.9%
P/S (TTM)
10.23
P/B
2.2
EPS (TTM)
$-9.42
CF/Share
$-79.22
Rev Growth 3Y
-60.6%
52W High
$55.89
52W Low
$5.20
$5.20
52-Week Range
$55.89
How does KRRO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
KRRO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
10.2
▼
20%
below
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.2
▼
10%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
KRRO profitability vs Biotechnology peers
ROE
-68.9%
▼
2%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-1199.5%
▼
318%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-45.9%
▲
2%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
KRRO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.7
▲
51%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
3.0
▲
211%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
KRRO fundamentals radar
KRRO
Peer median
Industry
KRRO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio